Our story

INOFEA - Empowering Enzymes

INOFEA AG is a Swiss biotech company founded in 2014 in Basel by a group of entrepreneurs and scientists as a spin-off from the School of Life Sciences, University of Applied Sciences and Arts, Northwestern Switzerland (FHNW), led by CEO Dr Yves Dudal.

We’ve created INOFEA from the desire to meet a critical need related to enzyme lack of stability and robustness: the possibility to provide enzymes with resistance to in vivo and process conditions, so that they could be fully deployed in the health industry.

Unlike other existing technologies, our innovative nanotechnology platform is capable of shielding sensitive enzymes and has positively demonstrated substantial benefits to customers in a number of health industry applications.